Engaging patients in decision making

Over the last 5 years Professor Gavin Giovannoni has received personal compensation for participating on Advisory Boards in relation to multiple sclerosis clinical trial design, trial steering committees and data and safety monitoring committees from: Abbvie, Actelion, Atara Bio, Biogen-Idec, Celgene, Sanofi-Genzyme, Genentech, GSK, GW Pharma, Merck, Merck KGaA, Novartis, Roche and Teva. Professor Giovannoni is Co-Editor-in-Chief of Multiple Sclerosis and Related Disorders and chairs the MS Brain Health initiative, MS Academy and triMS.online conference. He has previously been a member of multiple sclerosis and related disorders specialist advisory group of the Association of British Neurologists and an ECTRIMS representative. He is a director of Oxford Health Policy Forum, a non-profit company.